GlassScriptPhysician profile
Marvin L Lu
NPI 1831522366
$37,728.71
in general payments reported to CMS, 2019-2025
26 companies · $5,019 in 2025
The $5,019 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $777 · 2022: $11K · 2023: $15K · 2024: $5,969 · 2025: $5,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Travel and Lodging: $8,611 · Education: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,578.08 |
| Travel and Lodging | $8,610.94 |
| Education | $433.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,843.23 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan |
| Abbott Laboratories | $9,508.51 | 2021-2025 | Ensite Precision, Aveir, Ensite |
| Boston Scientific Corporation | $5,078.40 | 2022-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Biotronik INC. | $3,867.98 | 2022-2023 | Sentus, Edora 8 Dr-T, Acticor 7 Vr-T Dx |
| Atricure, INC. | $1,352.54 | 2021-2024 | |
| Aop Health US, LLC | $1,154.90 | 2025 | Rapiblyk |
| Biosense Webster, INC. | $1,047.32 | 2023-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Philips North America LLC | $773.60 | 2023-2024 | (Cm9) Amb Mon & Diag Und |
| Cardiva Medical, INC. | $401.30 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $337.48 | 2023-2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $239.06 | 2025 | Evoque, Sapien 3 Ultra Resilia |
| Abiomed | $202.49 | 2023-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $173.47 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $153.29 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.59 | 2024-2025 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $97.00 | 2023-2024 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $62.98 | 2023-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $57.22 | 2024-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $48.60 | 2023-2025 | Onpattro, Amvuttra |
| Cleerly, INC. | $45.07 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.97 | 2024-2025 | Jardiance |
| Cordis US Corp. | $30.89 | 2025 | Mynx Control Venous |
| Kiniksa Pharmaceuticals International, Plc | $21.91 | 2024 | Arcalyst |
| Acutus Medical, INC. | $21.63 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.15 | 2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $13.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.